Arkema pays for 10s while short dated FRNs extend run
Parts of the corporate bond primary market showed signs of strain on Tuesday with one rare issuer, Arkema, pricing a €700m 10 year trade with an 11bp premium over fair value — one of the largest premia for a vanilla corporate trade in recent weeks.
Bankers off the trade put this down to a mixture of the Baa2/BBB rated French chemical company Arkema being a tough sell and investors demanding higher premia after months of borrowers paying wafer thin concessions.“Arkema is not hugely loved, so it’s a decent outcome ...
Please take a trial or subscribe to access this content.
Contact our subscriptions team to discuss your access: firstname.lastname@example.org